CYRPA International

C-RAD enters North American market with C-RAD Inc subsidiary. C-RAD enter Australian and New Zealand market with subsidiary. C-RAD monitors the patient’s motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort. C-RAD delivers patient-centric and user-friendly Surface Guided Radiation Therapy (SGRT) for effective radiotherapy treatments and better clinical outcomes. We develop technologies with the mission to help cure more cancer patients and improve their quality of life, partnering with clinics and treatment centers around the world. C-RAD’s cutting-edge solutions ensure exceptionally high precision, safety and efficiency in advanced radiation therapy, helping to cure more cancer patients and improve their quality of life. Our knowledgeable and experienced C-RAD Services team is here for you during the entire lifetime of the systems. We’re on a mission to help cure more cancer patients and improve their quality of life, partnering with clinics and treatment centers around the world.